Showing results (781-790 of 851) with videos related to
Sort By:
Pageof 86
Journal of Medicinal Chemistry|July 13, 2023
Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical DevelopmentVincent Guerlavais, Tomi K Sawyer, Luis Carvajal, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2015
A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)S Ramalingam, G Goss, R Rosell, et al.Genes & Development|October 15, 2016
Condensin II mutation causes T-cell lymphoma through tissue-specific genome instabilityJessica Woodward, Gillian C Taylor, Dinesh C Soares, et al.Inflammopharmacology|July 9, 2024
New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/organoprotectionPredrag Sikiric, Marko Sever, Ivan Krezic, et al.Biomolecules|November 27, 2021
Genetic and Metabolic Determinants of Atrial Fibrillation in a General Population Sample: The CHRIS StudyDavid B Emmert, Vladimir Vukovic, Nikola Dordevic, et al.Histopathology|February 13, 2013
Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutationsDaniel Wetterskog, Paul M Wilkerson, Daniel N Rodrigues, et al.BMC Oral Health|July 9, 2024
A scoping review of the links between early childhood caries and clean water and sanitation: the Sustainable Development Goal 6Yasmi O Crystal, Yuanyuan Laura Luo, Duangporn Duangthip, et al.European Journal of Epidemiology|May 21, 2018
Tumour stage and gender predict recurrence and second primary malignancies in head and neck cancer: a multicentre study within the INHANCE consortiumEmanuele Leoncini, Vladimir Vukovic, Gabriella Cadoni, et al.Iscience|June 22, 2026
Preclinical assessment of broadly neutralizing HIV-1 antibody BNT351 with optimized pharmacokinetics and potent antiviral activitySven Kratochvil, Maximilian Kullmann, Henning Gruell, et al.JCO Oncology Practice|February 13, 2020
Oncologist Burnout Syndrome in Eastern Europe: Results of the Multinational SurveyDavor Kust, Jure Murgic, Petra Vukovic, et al.Pageof 86